Inhaled Treprostinil for COPD Patients with Low Oxygen

Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

Recruiting Phase 2 Interventional Study
COPD (Chronic Obstructive Pulmonary Disease) Hypoxemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
10 (estimated)
Sponsor
Bastiaan Driehuys · Other
Who this trial is looking for

This trial is looking for adults with chronic obstructive pulmonary disease (COPD) and low oxygen levels. Participants will use an inhaler with Treprostinil four times a day for four weeks and undergo several lung tests to see if the treatment helps improve lung function and oxygen delivery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 40 years old.
  • I have a history of chronic bronchitis.
  • I am a current or former smoker with a history of 20 or more pack-years.
  • I have been diagnosed with COPD.
  • I am using stable maintenance medications for COPD.
  • I have low oxygen levels and use supplemental oxygen.
  • I can give informed consent and follow study instructions.
  • I have a negative pregnancy test if I am a woman of childbearing potential.

You may not be able to join if

  • I had an upper respiratory infection in the last 6 weeks.
  • I have had lung surgery in the past.
  • I have a history of pneumothorax.
  • I have imaging evidence of serious lung disease.
  • I have a history of asthma.
  • I have exposure to harmful substances that could affect my lungs.
  • I have a positive pregnancy test if I am a woman of childbearing potential.
  • I have a major chronic illness that may affect my participation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether inhaled Treprostinil (Tyvaso) can improve oxygen delivery and blood flow in the lungs in adults (age ≥40) with chronic obstructive pulmonary disease (COPD) and hypoxemia who have less severe reduction in lung blood volume (diffusing capacity of the lungs for carbon monoxide \[DLCO\] ≥45%). The main questions it aims to answer are: 1. Does in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Outpatients of either gender, age ≥ 40. * Clinical evidence of chronic bronchitis (a productive cough lasting more than 3 months within a 2-year period). * Current or former cigarette smokers with a smoking history of 20 or more pack-years. * Clinical diagnosis of chronic obstr…
Contacts

Yuh-Chin Huang, M.D., M.H.S., MD

919-684-3069

yuhchin.huang@duke.edu

CONTACT

Savannah Barbieri

919-613-0740

savannah.barbieri@duke.edu

CONTACT